ABPI statement on the death of Her Majesty Queen Elizabeth II
08 September 2022
Posted in News
by Press Office
ABPI statement on the death of Her Majesty Queen Elizabeth II:
On behalf of the ABPI and the pharmaceutical industry in the UK, I would like to extend our condolences to the Royal Family. Richard Torbett, Chief Executive, ABPI
ABPI Chief Executive Richard Torbett said:
“On behalf of the ABPI and the pharmaceutical industry in the UK, I would like to extend our condolences to the Royal Family.
“The Queen led a life of duty and service to the people of the UK & Commonwealth and was an inspirational figurehead for the UK around the world.
“She leaves behind an unmatched legacy of dignified leadership and our industry joins with the rest of the nation in mourning at this sad time.”
Last modified: 20 September 2023
Last reviewed: 20 September 2023